Rench Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.25M Sell
43,671
-1,382
-3% -$160K 1.58% 25
2025
Q4
$4.74M Sell
45,053
-507
-1% -$47.6K 1.36% 30
2025
Q3
$3.82M Buy
45,560
+432
+1% +$35.6K 1.12% 35
2025
Q2
$3.57M Buy
45,128
+1,281
+3% +$102K 1.13% 36
2025
Q1
$3.94M Buy
43,847
+640
+1% +$59.8K 1.36% 34
2024
Q4
$4.3M Buy
43,207
+91
+0.2% +$9.38K 1.47% 31
2024
Q3
$4.9M Buy
43,116
+564
+1% +$67K 1.68% 28
2024
Q2
$5.27M Sell
42,552
-344
-0.8% -$44.3K 1.89% 22
2024
Q1
$5.66M Sell
42,896
-878
-2% -$108K 2.17% 17
2023
Q4
$4.77M Sell
43,774
-1,829
-4% -$190K 2.01% 24
2023
Q3
$4.69M Sell
45,603
-353
-0.8% -$38K 2.16% 20
2023
Q2
$5.3M Sell
45,956
-123
-0.3% -$14K 2.33% 17
2023
Q1
$4.9M Sell
46,079
-13,557
-23% -$1.46M 2.35% 17
2022
Q4
$6.62M Sell
59,636
-870
-1% -$88.9K 3.36% 8
2022
Q3
$5.21M Sell
60,506
-545
-0.9% -$48.7K 2.92% 12
2022
Q2
$5.57M Sell
61,051
-346
-0.6% -$30.7K 2.85% 13
2022
Q1
$5.04M Sell
61,397
-2,631
-4% -$207K 2.29% 22
2021
Q4
$4.91M Buy
64,028
+277
+0.4% +$22.1K 2.21% 20
2021
Q3
$4.79M Buy
63,751
+922
+1% +$70.1K 2.38% 20
2021
Q2
$4.89M Buy
62,829
+15
+0% +$1.12K 2.44% 19
2021
Q1
$4.62M Buy
62,814
+3,466
+6% +$256K 2.4% 19
2020
Q4
$4.63M Buy
59,348
+4,064
+7% +$311K 2.61% 18
2020
Q3
$4.38M Buy
55,284
+5,843
+12% +$458K 2.78% 17
2020
Q2
$3.65M Buy
49,441
+1,893
+4% +$143K 2.46% 19
2020
Q1
$3.49M Buy
47,548
+1,380
+3% +$108K 2.71% 17
2019
Q4
$4.01M Buy
46,168
+4,641
+11% +$381K 2.31% 20
2019
Q3
$3.34M Buy
41,527
+1,392
+3% +$112K 2.16% 24
2019
Q2
$3.21M Sell
40,135
-150
-0.4% -$11.5K 2.06% 22
2019
Q1
$3.2M Sell
40,285
-1,898
-4% -$142K 2.09% 21
2018
Q4
$3.08M Buy
42,183
+531
+1% +$37.5K 2.25% 20
2018
Q3
$2.82M Buy
41,652
+1,135
+3% +$72.3K 1.88% 26
2018
Q2
$2.35M Sell
40,517
-120
-0.3% -$6.77K 1.69% 32
2018
Q1
$2.11M Buy
40,637
+812
+2% +$43.9K 1.44% 38
2017
Q4
$2.14M Buy
39,825
+2,303
+6% +$128K 1.39% 39
2017
Q3
$2.29M Buy
37,522
+3,637
+11% +$221K 1.58% 35
2017
Q2
$2.07M Buy
33,885
+191
+0.6% +$11.6K 1.53% 33
2017
Q1
$2.04M Buy
33,694
+269
+0.8% +$16.3K 1.52% 34
2016
Q4
$1.88M Buy
33,425
+2,506
+8% +$147K 1.49% 33
2016
Q3
$1.84M Sell
30,919
-3,506
-10% -$205K 1.49% 34
2016
Q2
$1.89M Buy
34,425
+982
+3% +$52.3K 1.53% 27
2016
Q1
$1.69M Sell
33,443
-175
-0.5% -$8.57K 1.39% 30
2015
Q4
$1.69M Sell
33,618
-1,468
-4% -$74K 1.46% 29
2015
Q3
$1.65M Buy
35,086
+2,380
+7% +$126K 1.52% 30
2015
Q2
$1.78M Sell
32,706
-504
-2% -$28.3K 1.55% 30
2015
Q1
$1.82M Sell
33,210
-5,241
-14% -$297K 1.56% 29
2014
Q4
$2.08M Sell
38,451
-3,912
-9% -$218K 1.75% 27
2014
Q3
$2.4M Buy
42,363
+100
+0.2% +$5.62K 2.05% 26
2014
Q2
$2.33M Buy
42,263
+1,448
+4% +$79K 2.04% 26
2014
Q1
$2.21M Sell
40,815
-4,760
-10% -$246K 2.09% 26
2013
Q4
$2.18M Buy
+45,575
New +$2.08M 2.11% 21

Other funds holding MRK

Rench Wealth Management's MRK Position: Q1 2026 in Review

Rench Wealth Management reduced its Merck (MRK) stake by 3.1% in Q1 2026, selling an estimated $160K and leaving 43,671 shares worth $5.25M. The position accounts for 1.58% of the portfolio, ranked #25.

Rench Wealth Management first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.62M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rench Wealth Management held 43,671 shares of Merck worth $5.25M as of Q1 2026.
  • Rench Wealth Management sold 1,382 Merck shares in Q1 2026, an estimated $160K.
  • Merck made up 1.58% of Rench Wealth Management's portfolio in Q1 2026, its #25 holding.
  • Rench Wealth Management first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
  • Rench Wealth Management's Merck position peaked at $6.62M in Q4 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rench Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.